Mosaic trisomy of chromosome 1q in human brain tissue associates with unilateral polymicrogyria, very early-onset focal epilepsy, and severe developmental delay DOI Creative Commons
Katja Kobow, Samir Jabari, Tom Pieper

et al.

Acta Neuropathologica, Journal Year: 2020, Volume and Issue: 140(6), P. 881 - 891

Published: Sept. 26, 2020

Abstract Polymicrogyria (PMG) is a developmental cortical malformation characterized by an excess of small and frustrane gyration abnormal lamination. PMG frequently associates with seizures. The molecular pathomechanisms underlying development are not yet understood. About 40 genes have been associated PMG, copy number variations also described in selected patients. We recently provided evidence that epilepsy-associated structural brain lesions can be classified based on genomic DNA methylation patterns. Here, we analyzed 26 patients employing array-based profiling formalin-fixed paraffin-embedded material. A series 62 well-characterized non-PMG malformations (focal dysplasia type 2a/b hemimegalencephaly), temporal lobe epilepsy, non-epilepsy autopsy controls was used as reference cohort. Unsupervised dimensionality reduction hierarchical cluster analysis profiles showed formed distinct class. Copy from data identified uniform duplication spanning the entire long arm chromosome 1 7 out patients, which verified additional fluorescence situ hybridization analysis. In respective cases, about 50% nuclei center lesion were 1q triploid. No chromosomal imbalance seen adjacent, architecturally normal-appearing tissue indicating mosaicism. Clinically, presented unilateral frontal or hemispheric without hemimegalencephaly, severe form intractable epilepsy seizure onset first months life, delay. Our results show among other according to their profile. One subset clinical features exhibits 1q.

Language: Английский

Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) DOI Creative Commons
Thomas Bonduelle, Till Hartlieb, Sara Baldassari

et al.

Acta Neuropathologica Communications, Journal Year: 2021, Volume and Issue: 9(1)

Published: Jan. 6, 2021

Abstract Focal malformations of cortical development (MCD) are linked to somatic brain mutations occurring during neurodevelopment. Mild malformation with oligodendroglial hyperplasia in epilepsy (MOGHE) is a newly recognized clinico-pathological entity associated pediatric drug-resistant focal epilepsy, and amenable neurosurgical treatment. MOGHE histopathologically characterized by clusters increased cell densities, patchy zones hypomyelination, heterotopic neurons the white matter. The molecular etiology remained unknown so far. We hypothesized contribution mosaic variants performed deep targeted gene sequencing on 20 surgical samples from single-center cohort patients. identified pathogenic SLC35A2 9/20 (45%) patients rates ranging 7 52%. encodes UDP-galactose transporter, previously implicated other rare type congenital disorder glycosylation. To further clarify histological features -brain tissues, we then collected 17 multicenter MCD cases. Histopathological reassessment including anti-Olig2 staining confirmed diagnosis all Analysis droplet digital PCR pools microdissected cells one tissue revealed variant enrichment clustered neurons. Through an international consortium, assembled unprecedented series 26 -MOGHE cases providing evidence that variants, likely occurred neuroglial progenitor development, genetic marker for MOGHE.

Language: Английский

Citations

110

Developmental and epileptic encephalopathies DOI
Ingrid E. Scheffer, Sameer M. Zuberi, Heather C. Mefford

et al.

Nature Reviews Disease Primers, Journal Year: 2024, Volume and Issue: 10(1)

Published: Sept. 5, 2024

Language: Английский

Citations

21

International consensus recommendations on the diagnostic work-up for malformations of cortical development DOI Creative Commons
Renske Oegema, Tahsin Stefan Barakat, Martina Wilke

et al.

Nature Reviews Neurology, Journal Year: 2020, Volume and Issue: 16(11), P. 618 - 635

Published: Sept. 7, 2020

Abstract Malformations of cortical development (MCDs) are neurodevelopmental disorders that result from abnormal the cerebral cortex in utero. MCDs place a substantial burden on affected individuals, their families and societies worldwide, as these individuals can experience lifelong drug-resistant epilepsy, palsy, feeding difficulties, intellectual disability other neurological behavioural anomalies. The diagnostic pathway for is complex owing to wide variations presentation aetiology, thereby hampering timely adequate management. In this article, international MCD network Neuro-MIG provides consensus recommendations aid both expert non-expert clinicians work-up with aim improving patient management worldwide. We reviewed literature clinical presentation, aetiology approaches main subtypes collected data current practices laboratories within Neuro-MIG. reached by 42 professionals 20 countries, using discussions Delphi process. present workflow be applied any individual comprehensive list MCD-related genes associated phenotypes. designed maximize yield increase number patients receiving personalized care counselling prognosis recurrence risk.

Language: Английский

Citations

98

Mapping the molecular and cellular complexity of cortical malformations DOI
Esther Klingler, Fiona Francis, Denis Jabaudon

et al.

Science, Journal Year: 2021, Volume and Issue: 371(6527)

Published: Jan. 21, 2021

The cerebral cortex is an intricate structure that controls human features such as language and cognition. Cortical functions rely on specialized neurons emerge during development from complex molecular cellular interactions. Neurodevelopmental disorders occur when one or several of these steps incorrectly executed. Although a number causal genes disease phenotypes have been identified, the sequence events linking disruption to clinical expression mostly remains obscure. Here, focusing malformations cortical development, we illustrate how interactions at genetic, cellular, circuit levels together contribute diversity variability in phenotypes. Using specific examples online resource, propose multilevel assessment processes key identifying points vulnerability developing new therapeutic strategies.

Language: Английский

Citations

95

Epilepsy in the mTORopathies: opportunities for precision medicine DOI Creative Commons
Patrick B. Moloney, Gianpiero L. Cavalleri,

Norman Delanty

et al.

Brain Communications, Journal Year: 2021, Volume and Issue: 3(4)

Published: Sept. 21, 2021

Abstract The mechanistic target of rapamycin signalling pathway serves as a ubiquitous regulator cell metabolism, growth, proliferation and survival. main cellular activity the cascade funnels through complex 1, which is inhibited by rapamycin, macrolide compound produced bacterium Streptomyces hygroscopicus. Pathogenic variants in genes encoding upstream regulators 1 cause epilepsies neurodevelopmental disorders. Tuberous sclerosis multisystem disorder caused mutations TSC1 or TSC2, with prominent neurological manifestations including epilepsy, focal cortical dysplasia neuropsychiatric Focal type II results from somatic brain activators MTOR, AKT3, PIK3CA RHEB major drug-resistant epilepsy. DEPDC5, NPRL2 NPRL3 code for subunits GTPase-activating protein (GAP) towards Rags (GATOR1), principal amino acid-sensing 1. Germline pathogenic GATOR1 non-lesional associated malformations development. Collectively, mTORopathies are characterized excessive activation In first large-scale precision medicine trial genetically mediated everolimus (a synthetic analogue rapamycin) was effective at reducing seizure frequency people tuberous complex. Rapamycin reduced seizures rodent models DEPDC5-related epilepsy II. This review outlines personalized approach to management mTORopathies. We advocate early diagnostic sequencing identification variant may point an occult apparently uncover important prognostic information including, increased risk sudden unexpected death GATORopathies favourable surgery outcomes due mutations. Lastly, we discuss potential therapeutic application inhibitors GATOR1-related

Language: Английский

Citations

86

Fetal Brain Development: Regulating Processes and Related Malformations DOI Creative Commons
Z. Leibovitz, Tally Lerman‐Sagie,

Leila Haddad

et al.

Life, Journal Year: 2022, Volume and Issue: 12(6), P. 809 - 809

Published: May 29, 2022

This paper describes the contemporary state of knowledge regarding processes that regulate normal development embryonic–fetal central nervous system (CNS). The are described according to developmental timetable: dorsal induction, ventral neurogenesis, neuronal migration, post-migration development, and cortical organization. We review current literature on CNS malformations associated with these regulating processes. specifically address neural tube defects, holoprosencephaly, (including microcephaly, megalencephaly, lissencephaly, cobblestone malformations, gray matter heterotopia, polymicrogyria), disorders corpus callosum, posterior fossa malformations. Fetal ventriculomegaly, which frequently accompanies disorders, is also reviewed. Each malformation reference etiology, genetic causes, prenatal sonographic imaging, anomalies, differential diagnosis, complimentary diagnostic studies, clinical interventions, neurodevelopmental outcome, life quality.

Language: Английский

Citations

41

Diagnostic Approach to Macrocephaly in Children DOI Creative Commons
Andrea Accogli, Ana Filipa Geraldo, Gianluca Piccolo

et al.

Frontiers in Pediatrics, Journal Year: 2022, Volume and Issue: 9

Published: Jan. 14, 2022

Macrocephaly affects up to 5% of the pediatric population and is defined as an abnormally large head with occipitofrontal circumference (OFC) >2 standard deviations (SD) above mean for a given age sex. Taking into account that about 2–3% healthy has OFC between 2 3 SD, macrocephaly considered “clinically relevant” when SD. This implies urgent need diagnostic workflow use in clinical setting dissect several causes increased OFC, from benign form familial Benign enlargement subarachnoid spaces (BESS) many pathological conditions, including genetic disorders. Moreover, should be differentiated by megalencephaly (MEG), which refers exclusively brain overgrowth, exceeding twice SD (3SD—“clinically megalencephaly). While can isolated or may first indication underlying congenital, genetic, acquired disorder, most likely due cause. Apart size evaluation, detailed family personal history, neuroimaging, careful evaluation are crucial reach correct diagnosis. In this review, we seek underline aspects megalencephaly, emphasizing main differential diagnosis major focus on common We thus provide clinico-radiological algorithm guide pediatricians assessment children macrocephaly.

Language: Английский

Citations

39

Bisphenol A (BPA) and neurological disorders: An overview DOI Creative Commons
Sung‐Ae Hyun, Minhan Ka

The International Journal of Biochemistry & Cell Biology, Journal Year: 2024, Volume and Issue: 173, P. 106614 - 106614

Published: June 28, 2024

Language: Английский

Citations

11

An overview of the value of mTOR inhibitors to the treatment of epilepsy: the evidence to date DOI
Patrick B. Moloney,

Norman Delanty

Expert Review of Neurotherapeutics, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 4, 2025

Introduction Dysregulated mechanistic target of rapamycin (mTOR) activity is implicated in seizure development epilepsies caused by variants mTOR pathway genes. Sirolimus and everolimus, allosteric inhibitors, are widely used transplant medicine oncology. Everolimus approved for treating seizures tuberous sclerosis complex (TSC), the prototype mTORopathy. Emerging evidence suggests that inhibitors could also be effective other mTORopathies, such as DEPDC5-related epilepsy focal cortical dysplasia type 2 (FCD2).

Language: Английский

Citations

1

Tubulin mutations in human neurodevelopmental disorders DOI Creative Commons

Camille Maillard,

Charles Joris Roux,

Fabienne Charbit‐Henrion

et al.

Seminars in Cell and Developmental Biology, Journal Year: 2022, Volume and Issue: 137, P. 87 - 95

Published: July 30, 2022

Language: Английский

Citations

31